Amyris secures $20 million 12% term loan due 2024 via Foris’ Muirisc

By Devika Patel

Knoxville, Tenn., Aug. 3 – Amyris, Inc. and some of its subsidiaries entered into a $20 million secured term loan facility with Muirisc, LLC, an affiliate of existing lender Foris Ventures, LLC, on Aug. 2, according to an 8-K filing with the Securities and Exchange Commission.

The full amount of the facility was drawn at closing.

The loan, which matures on Oct. 31, 2024, carries a 12% fixed interest rate.

Proceeds will be used for working capital and general corporate purposes.

Amyris is an Emeryville, Calif.-based biotechnology company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.